Top compounds associated with response to HNRNPD


Feature Type Standardized
Nominal ANOVA
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA QL-XI-92 GDSC1000 pan-cancer AAC 0.13 0.0002
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA KPT185 CTRPv2 pan-cancer AAC 0.15 0.0003
mRNA Vorinostat gCSI pan-cancer AAC 0.18 0.0003
mRNA Y-39983 GDSC1000 pan-cancer AAC 0.13 0.0003
Download CSV